Effects of valproic acid on the cell cycle and apoptosis through acetylation of histone and tubulin in a scirrhous gastric cancer cell line

Author:

Yagi Yasumichi,Fushida Sachio,Harada Shinichi,Kinoshita Jun,Makino Isamu,Oyama Katsunobu,Tajima Hidehiro,Fujita Hideto,Takamura Hiroyuki,Ninomiya Itasu,Fujimura Takashi,Ohta Tetsuo,Yashiro Masakazu,Hirakawa Kosei

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Reference61 articles.

1. Souza RF, Spechler SJ: Concepts in the prevention of adenocarcinoma of the distal esophagus and proximal stomach. CA cancer J Clin. 2005, 55: 334-51.

2. Ikeguchi M, Miyake T, Matsunaga T, et al: Recent results of therapy for scirrhous gastric cancer. Surg Today. 2009, 39: 290-4.

3. Chen CY, Wu CW, Lo SS, Hsieh MC, Lui WY, Shen KH: Peritoneal carcinomatosis and lymph node metastasis are prognostic indicators in patients with Borrmann type IV gastric carcinoma. Hepatogastroenterology. 2002, 49: 874-7.

4. Ishigami H, Kitayama J, Kaisaki S, et al: Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis. Ann Oncol. 2010, 21: 67-70.

5. Fushida S, Kinoshita J, Yagi Y, et al: Dual anti-cancer effects of weekly intraperitoneal docetaxel in treatment of advanced gastric cancer patients with peritoneal carcinomatosis: a feasibility and pharmacokinetic study. Oncol Rep. 2008, 19: 1305-10.

Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Mechanistic Insights about Sorafenib-, Valproic Acid- and Metformin-Induced Cell Death in Hepatocellular Carcinoma;International Journal of Molecular Sciences;2024-02-01

2. HDAC2 as a target for developing anti-cancer drugs;Computational and Structural Biotechnology Journal;2023

3. Drug Repurposing in Gastric Cancer: Current Status and Future Perspectives;Hereditary Gastric and Breast Cancer Syndrome;2023

4. Repurposed Drugs in Gastric Cancer;Molecules;2022-12-30

5. Manipulating histone acetylation leads to antitumor effects in hemangiosarcoma cells;Veterinary and Comparative Oncology;2022-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3